Back to Search Start Over

Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter study.

Authors :
Atsukawa, Masanori
Tsubota, Akihito
Kondo, Chisa
Koyano, Kaori-Shioda
Ishikawa, Toru
Toyoda, Hidenori
Takaguchi, Koichi
Watanabe, Tsunamasa
Matsuura, Kentaro
Ogawa, Chikara
Hiraoka, Atsushi
Okubo, Hironao
Tateyama, Masakuni
Uojima, Haruki
Nozaki, Akito
Chuma, Makoto
Kato, Keizo
Mikami, Shigeru
Tani, Joji
Morishita, Asahiro
Source :
Hepatology International; Feb2023, Vol. 17 Issue 1, p139-149, 11p
Publication Year :
2023

Abstract

Background: Tricuspid regurgitation pressure gradient (TRPG) measurement by echocardiography is recommended as the most objective examination to detect portopulmonary hypertension (PoPH). This study aimed to identify factors associated with a high TRPG in patients with cirrhosis and develop a scoring model for identifying patients who are most likely to benefit from echocardiography investigations. Results: A total of 486 patients who underwent echocardiography were randomly allocated to the derivation and validation sets at a ratio of 2:1. Of the patients, 51 (10.5%) had TRPG ≥ 35 mmHg. The median brain natriuretic peptide (BNP) was 39.5 pg/mL. Shortness of breath (SOB) was reported by 91 (18.7%) patients. In the derivation set, multivariate analysis identified female gender, shortness of breath, and BNP ≥ 48.9 pg/mL as independent factors for TRPG ≥ 35 mmHg. The risk score for predicting TRPG ≥ 35 mmHg was calculated as follows: − 3.596 + 1.250 × gender (female: 1, male: 0) + 1.093 × SOB (presence: 1, absence: 0) + 0.953 × BNP (≥ 48.9 pg/mL: 1, < 48.9 pg/mL: 0). The risk score yielded sensitivity of 66.7%, specificity of 75.3%, positive predictive value of 25.5%, negative predict value of 94.3%, and predictive accuracy of 74.4% for predicting TRPG ≥ 35 mmHg. These results were almost similar in the validation set, indicating the reproducibility and validity of the risk score. Conclusions: This study clarified the characteristics of patients with suspected PoPH and developed a scoring model for identifying patients at high risk of PoPH, which may be used in selecting patients that may benefit from echocardiography. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
19360533
Volume :
17
Issue :
1
Database :
Complementary Index
Journal :
Hepatology International
Publication Type :
Academic Journal
Accession number :
161653598
Full Text :
https://doi.org/10.1007/s12072-022-10456-y